trial · primary record
Biopsy Procedure
Renal Pelvis and Ureter Urothelial Carcinoma
| Phase | Phase 2, Phase 3 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 131 |
| Primary completion | 2027-09-30 |
| Primary endpoint | Event-free survival (EFS) (Cisplatin eligible cohort: Arms A and B) |
| Registry ID | NCT04628767 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:33:05.567Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT04628767
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.